Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Chemoradiotherapy × Clear all

Status

Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Rectal Neoplasms 9 Esophageal Neoplasms 6 Oropharyngeal Neoplasms 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Carcinoma, Non-Small-Cell Lung 4 Head and Neck Neoplasms 3 Nasopharyngeal Carcinoma 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Vaginal Neoplasms 1 Uterine Cervical Dysplasia 1 Sinonasal Squamous Cell Carcinoma 1 Rectal Malignant Neoplasms 1 Radiation Injuries 1 Postoperative Complications 1 Pathologic Complete Response 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ototoxicity 1 Neoplasms 1 Myelosuppression 1 Mouth Neoplasms 1 Margins of Excision 1 Malignant Tumor of Lacrimal Drainage Structure 1 Lung Neoplasms 1 Low Anterior Resection Syndrome 1 Locally Advanced Hypopharyngeal Carcinoma 1 Locally Advanced Cervical Cancer 1

Interventions

pembrolizumab 35 Blood Specimen Collection 34 Bevacizumab 18 Standard of Care 16 Radiotherapy 15 Carboplatin 15 Surveys and Questionnaires 13 Paclitaxel 13 Nivolumab 13 Exercise 13 Drug Therapy 11 Cisplatin 11 atezolizumab 10 Docetaxel 10 Dexamethasone 10 Cyclophosphamide 10 Fluorouracil 9 Trastuzumab 8 Pemetrexed 8 Leucovorin 8 Cetuximab 8 pertuzumab 7 olaparib 7 Temozolomide 7 Oxaliplatin 7 Observation 7 Irinotecan 7 Interviews as Topic 7 Radiosurgery 6 Panitumumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡